✦ LIBER ✦

PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER

✍ Scribed by SAINT, FABIEN; PATARD, JEAN J.; MAILLE, PASCALE; SOYEUX, PASCALE; HOZNEK, ANDRÉ; SALOMON, LAURENT; ABBOU, CLAUDE C.; CHOPIN, DOMINIQUE K.

Book ID: 123298685
Publisher: Lippincott Williams and Wilkins
Year: 2002
Tongue: English
Weight: 68 KB
Volume: 167
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)65469-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urinary IL-2 assay for monitoring intrav

Urinary IL-2 assay for monitoring intravesical bacillus calmette-guérin (BCG) response of superficial bladder cancer during induction course and maintenance therapy

✍ F. Saint; P. Maille; D. Vordos; A. Hoznek; P. Soyeux; J.J. Patard; C.C. Abbou; D 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Evolution and Clinical Significance of t

Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer

✍ Zlotta, Alexandre R.; Drowart, Annie; Van Vooren, Jean-Paul; de Cock, Michel; Pi 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 859 KB

INTRAVESICAL INSTILLATION OF EPIRUBICIN,

INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIAL

✍ VAN DER MEIJDEN, ADRIAN P.M.; BRAUSI, MAURIZIO; ZAMBON, VICTOR; KIRKELS, WIM; DE 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 140 KB

Maintenance Bacillus Calmette-Guerin for

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

✍ Adrian P.M. van der Meijden; Richard J. Sylvester; Wim Oosterlinck; Wolfgang Hoe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 105 KB

The Side Effects of Bacillus Calmette-Gu

The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

✍ Richard J. Sylvester; Adrian P.M. van der Meijden; Wim Oosterlinck; Wolfgang Hoe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Commentary on “The value of transurethra

Commentary on “The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.” Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria

✍ Kamat, Ashish M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 128 KB